Patents by Inventor Soroush Mohammad Mirzaei Zarandi

Soroush Mohammad Mirzaei Zarandi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10653346
    Abstract: A low cost portable high speed quantitative system for diffuse optical spectroscopic imaging of human tissue. The hybrid system (CWFD) can measure absolute optical properties from 660 nm to 980 nm and recover all tissue chromophore concentrations. The standalone FD module can be utilized to measure scattering at every measurement and recover deoxygenated and oxygenated hemoglobin concentrations. The CW module can operate concurrently with the FD module to also measure water and lipid. The high temporal resolution and large signal-to-noise ratio of the CWFD system may be used to explore tissue oximetry, vascular occlusion, and paced breathing models to measure and analyze tissue hemodynamics response to changes in blood flow. Continuous monitoring of vasculature response to various modified blood perfusion conditions can provide information about local tissue metabolism and physiological state (dysfunction).
    Type: Grant
    Filed: January 26, 2017
    Date of Patent: May 19, 2020
    Assignee: The Regents of the University of California
    Inventors: Soroush Mohammad Mirzaei Zarandi, Bruce J. Tromberg, Thomas D. O'Sullivan, Siavash Sedighzadeh Yazdi, Albert Cerussi
  • Publication number: 20170209083
    Abstract: A low cost portable high speed quantitative system for diffuse optical spectroscopic imaging of human tissue. The hybrid system (CWFD) can measure absolute optical properties from 660 nm to 980 nm and recover all tissue chromophore concentrations. The standalone FD module can be utilized to measure scattering at every measurement and recover deoxygenated and oxygenated hemoglobin concentrations. The CW module can operate concurrently with the FD module to also measure water and lipid. The high temporal resolution and large signal-to-noise ratio of the CWFD system may be used to explore tissue oximetry, vascular occlusion, and paced breathing models to measure and analyze tissue hemodynamics response to changes in blood flow. Continuous monitoring of vasculature response to various modified blood perfusion conditions can provide information about local tissue metabolism and physiological state (dysfunction).
    Type: Application
    Filed: January 26, 2017
    Publication date: July 27, 2017
    Applicant: The Regents of the University of California
    Inventors: Soroush Mohammad Mirzaei Zarandi, Bruce J. Tromberg, Thomas D. O'Sullivan, Siavash Sedighzadeh Yazdi, Albert Cerussi